Skip to content

MozecTM NC Rx PTCA Balloon Dilatation Catheter MNC25035Recalls & reported problems

Meril Life Sciences Private Limited · MozecTM NC Rx PTCA Balloon Dilatation Catheter, 2.50 mm x 35 mm, Rapid Exchange · Class 2

All models of MozecTM NC Rx PTCA Balloon Dilatation Catheter (15)

Data updated Oct 18, 2026 from official FDA records · Editorial policy

Adverse event reports
1
Deaths reported
0
Injuries reported
0
Recalls naming it
0

Summary

The FDA's MAUDE database contains 1 adverse event report that list this exact device (DI 18906029359350), received between Nov 30, 2019 and Nov 30, 2019 — classified as 1 malfunction.

The most frequently reported specific device problem is “Material Rupture” (1 report).

Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. What reports can and can't tell you · How this data works · Data updated Oct 18, 2026.

Most reported problems

Device problems

  • Material Rupture1

Patient problems

  • No Consequences Or Impact To Patient1

Recent adverse event reports

The 1 most recent of 1 reports, in the reporter's own words as published by the FDA.

  • MalfunctionNov 30, 2019Material Rupture; Material Rupture

    AS REPORTED, A 2.50 X 35 MM MOZECTM NC - RX PTCA BALLOON DILATATION CATHETER WAS USED FOR THE PROCEDURE. DURING INFLATION THE BALLOON BURST. THERE IS NO PATIENT INJURY REPORTED.

    Patient problems: No Consequences Or Impact To Patient

    MAUDE report 9392241 ↗

Other Catheters, Transluminal Coronary Angioplasty, Percutaneous devices

All Catheters, Transluminal Coronary Angioplasty, Percutaneous devices →

Sources and updates

How reports and recalls are matched · Editorial policy · Report an error on this page